Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

Parkinson Disease (PD) Clinical Trial

Official title:
Canadian Advanced Parkinson DUODOPA-Treated Patients Observational Study Evaluating Long-Term Health Outcomes in Centers of Excellence (CADENCE)

Status Completed

Clinical Trial Summary

This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with Duodopa (levodopa/carbidopa intestinal gel).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02485600
Study type	Observational
Source	AbbVie
Contact
Status	Completed
Phase
Start date	October 19, 2015
Completion date	February 26, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03840252` - Progression of Striatal and Extrastriatal Degeneration in PD and PSP Patients	N/A
Withdrawn	`NCT05033912` - A Study of CST-2032 in Subjects With Cognitive Impairment	Phase 1
Completed	`NCT03961282` - CODY (Co-design for You): An Immersive Technology Tool for Experiencing and Assessing Home Alterations	N/A
Active, not recruiting	`NCT04041193` - An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)	N/A
Recruiting	`NCT05395624` - Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers	Phase 1/Phase 2